2024 CSANZ Position Statement on Indications, Assessment and Monitoring of Structural and Valvular Heart Disease With Transthoracic Echocardiography in Adults

Heart Lung Circ. 2024 Jun;33(6):773-827. doi: 10.1016/j.hlc.2023.11.028. Epub 2024 May 14.

Abstract

Transthoracic echocardiography (TTE) is the most widely available and utilised imaging modality for the screening, diagnosis, and serial monitoring of all abnormalities related to cardiac structure or function. The primary objectives of this document are to provide (1) a guiding framework for treating clinicians of the acceptable indications for the initial and serial TTE assessments of the commonly encountered cardiovascular conditions in adults, and (2) the minimum required standard for TTE examinations and reporting for imaging service providers. The main areas covered within this Position Statement pertain to the TTE assessment of the left and right ventricles, valvular heart diseases, pericardial diseases, aortic diseases, infective endocarditis, cardiac masses, pulmonary hypertension, and cardiovascular diseases associated with cancer treatments or cardio-oncology. Facilitating the optimal use and performance of high quality TTEs will prevent the over or under-utilisation of this resource and unnecessary downstream testing due to suboptimal or incomplete studies.

Keywords: Comprehensive; Indications; Serial; Surveillance; Transthoracic echocardiography.

MeSH terms

  • Adult
  • Cardiology / methods
  • Cardiology / standards
  • Echocardiography* / methods
  • Echocardiography* / standards
  • Heart Valve Diseases* / diagnosis
  • Heart Valve Diseases* / diagnostic imaging
  • Humans
  • Practice Guidelines as Topic
  • Societies, Medical